Literature DB >> 16674629

Intraperitoneal fluid therapy: an alternative to intravenous treatment in a patient with limited vascular access.

P Asheim1, P E Uggen, K Aasarød, P Aadahl.   

Abstract

We describe a 58-year-old female with Crohn's disease and short bowel syndrome after repeated intestinal resections, with only 90 cm of small intestine left. She had been dependent on vascular access for total parenteral nutrition for 16 years. Due to intravascular complications after numerous long-term central venous catheters, her vascular accessibility became limited. During the course of a year she was fed enterally through a gastrostomy, but required supplementary fluid therapy through peripheral venous route. Because of extremely limited venous access, we decided to implant an intraperitoneal catheter for administration of crystalloid fluid. The first intraperitoneal catheter had to be removed because of a postoperative infection, but after antibiotic treatment, a second intraperitoneal catheter was implanted without complications, through which the patient is now fully provided with crystalloid fluid (Ringer's acetate). Abdominal ultrasound examination shows good absorption of the fluid, and for the first time in 16 years the patient does not need intravascular access. We suggest that intraperitoneal administration of fluid may be an alternative for patients with limited vascular access.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674629     DOI: 10.1111/j.1365-2044.2006.04615.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  The Effects of Acute Blood Loss for Diagnostic Bloodwork and Fluid Replacement in Clinically Ill Mice.

Authors:  James O Marx; JanLee A Jensen; Stacie Seelye; Raquel M Walton; F Claire Hankenson
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

2.  Medical and surgical management of the pediatric patient with intestinal failure.

Authors:  Frances R Malone; Simon P Horslen
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.